Iwamoto Kazuya, Nakatani Noriaki, Bundo Miki, Yoshikawa Takeo, Kato Tadafumi
Laboratory for Molecular Dynamics of Mental Disorders, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako city, Saitama 351 0198, Japan.
Neurosci Res. 2005 Sep;53(1):69-76. doi: 10.1016/j.neures.2005.06.001.
Altered RNA editing of serotonin 2C receptor (HTR2C) has been suggested to be involved in the pathophysiology of major depression. Here we examined RNA editing status of HTR2C in the learned helplessness (LH) rats, one of well-established animal models of depression. LH rats showed the significantly increased RNA editing of site E, and tendency for increased RNA editing of other editing sites. Treatment with fluoxetine, a selective serotonin reuptake inhibitor, or imipramine, a tricyclic antidepressant, affected the RNA editing status of the LH rats. Although, these antidepressants differentially altered RNA editing status, they commonly reduced RNA editing efficiency of site E. We further revealed that altered RNA editing in the LH rats and by antidepressants was not explained by altered expression of RNA editing enzymes or their substrates (adenosine deaminases that act on RNA, HTR2C, and spliced form of HTR2C). These results suggest that alteration of RNA editing of HTR2C may play a role in the pathophysiology of depression and action of antidepressants.
血清素2C受体(HTR2C)的RNA编辑改变被认为与重度抑郁症的病理生理学有关。在此,我们研究了习得性无助(LH)大鼠中HTR2C的RNA编辑状态,LH大鼠是一种成熟的抑郁症动物模型。LH大鼠的E位点RNA编辑显著增加,其他编辑位点的RNA编辑有增加趋势。用选择性5-羟色胺再摄取抑制剂氟西汀或三环类抗抑郁药丙咪嗪治疗会影响LH大鼠的RNA编辑状态。虽然这些抗抑郁药对RNA编辑状态的改变有所不同,但它们通常会降低E位点的RNA编辑效率。我们进一步发现,LH大鼠以及抗抑郁药引起的RNA编辑改变不能用RNA编辑酶或其底物(作用于RNA的腺苷脱氨酶、HTR2C和HTR2C的剪接形式)表达的改变来解释。这些结果表明,HTR2C的RNA编辑改变可能在抑郁症的病理生理学和抗抑郁药的作用中发挥作用。